Colorectal cancer metastases: evaluate current practice before introducing the “next new thing”
The story of colorectal cancer metastasectomy does not end with Treasure and colleagues' fascinating tale. 1 A recent randomised trial looked at the usefulness of positron emission tomography-computed tomography (PET-CT) for identifying suitable candidates for colorectal cancer liver metastasis...
Gespeichert in:
Veröffentlicht in: | BMJ (Online) 2014-06, Vol.348 (jun11 5), p.g3729-g3729 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The story of colorectal cancer metastasectomy does not end with Treasure and colleagues' fascinating tale. 1 A recent randomised trial looked at the usefulness of positron emission tomography-computed tomography (PET-CT) for identifying suitable candidates for colorectal cancer liver metastasis surgery. 2 Unlike an earlier trial, which had profound weaknesses, it found no evidence of benefit from PET-CT. 3 4 Both trials investigated whether patients could be spared unnecessary surgery because of unresectable metastatic spread identified by PET-CT. [...]intensive carcinoembryonic antigen (or CT) screening in colorectal cancer follow-up is used to detect recurrence as early as possible, then an aggressive surgical approach is pursued, and afterwards additional advanced diagnostic imaging (PET-CT) is used to exclude patients from surgery again. |
---|---|
ISSN: | 0959-8138 1756-1833 1756-1833 |
DOI: | 10.1136/bmj.g3729 |